North Carolina · Nonprofit
ASSOCIATION FOR OCULAR PHARMACOLOGY & THERAPEUTICS
ASSOCIATION FOR OCULAR PHARMACOLOGY & THERAPEUTICS (North Carolina) receives grants from 1 organization whose IRS filings report $20,000 to it, the largest being BRIGHTFOCUS FOUNDATION ($20,000). 1 of them have funded it in more than one year.
- Revenue FY2025
- $3k
- Funders on record
- 1
- Grants received
- $20k
- Net assets
- $167k
What Association for Ocular Pharmacology & Therapeutics does
Mission
To serve as a global forum and network for the publication, dissemination and exchange of information and knowledge of eye diseases.
As stated on its FY2025 Form 990.
Program
Provides an opportunity for scientific discussions and conducts meetings.
$190,341 spent$133,752 earned by the program100% of program spending
The program described on its FY2023 Form 990. Program spending in total: $190,341.
The organization over time
Each line starts at 100 in 2019, so what you read is the shape rather than the size: 150 means half as much again as 2019, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2024 to 2025, from $166k to $167k (+0%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
Government-grant reliance: 2024 17%. Grants only. Government contracts and fees sit inside program revenue.
26% of ASSOCIATION FOR OCULAR PHARMACOLOGY & THERAPEUTICS’s revenue is contributions — more earned-revenue than three-quarters of its peers (100% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 0 of the last 4 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Who funds it, year by year
2019 → 2021: the base held at 1 funder, grant income held at $10k.
From the IRS filings of ASSOCIATION FOR OCULAR PHARMACOLOGY & THERAPEUTICS’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Where its funders are
ASSOCIATION FOR OCULAR PHARMACOLOGY & THERAPEUTICS draws 100% of its grant income from funders outside North Carolina, across 1 state in all.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
ASSOCIATION FOR OCULAR PHARMACOLOGY & THERAPEUTICS runs a healthier operating margin than half of the 6,360 health nonprofits its size.
this organization peer median middle 50% of peers· 6,360 health nonprofits under $100k, FY2025
Organizations like ASSOCIATION FOR OCULAR PHARMACOLOGY & THERAPEUTICS
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In North Carolina
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
0% of spending goes to programs.
Governance
Public support
99%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Screen this organization
A dated, signed PDF of the compliance screen for ASSOCIATION FOR OCULAR PHARMACOLOGY & THERAPEUTICS: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds ASSOCIATION FOR OCULAR PHARMACOLOGY & THERAPEUTICS?
- ASSOCIATION FOR OCULAR PHARMACOLOGY & THERAPEUTICS (North Carolina) receives grants from 1 organization whose IRS filings report $20,000 to it, the largest being BRIGHTFOCUS FOUNDATION ($20,000). 1 of them have funded it in more than one year.
- How many funders does ASSOCIATION FOR OCULAR PHARMACOLOGY & THERAPEUTICS have?
- IRS filings report 1 organization giving $20,000 in grants to ASSOCIATION FOR OCULAR PHARMACOLOGY & THERAPEUTICS, 1 of which have funded it in more than one year.
- Who is the largest funder of ASSOCIATION FOR OCULAR PHARMACOLOGY & THERAPEUTICS?
- BRIGHTFOCUS FOUNDATION is the largest funder on record, with $20,000 in grants. The full list of funders is on this page.
- How can an organization like ASSOCIATION FOR OCULAR PHARMACOLOGY & THERAPEUTICS find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in North Carolina. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
Play a game about who funds Association for Ocular Pharmacology & Therapeutics →
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2019–2025), and the filings of 1 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing